Tumor-Agnostic Therapies: Is The TAPUR Study Right For You?
Diagnosis and Treatment, Clinical Research, Research, Medical Community, Novel Treatments Our MBClife Diagnosis and Treatment, Clinical Research, Research, Medical Community, Novel Treatments Our MBClife

Tumor-Agnostic Therapies: Is The TAPUR Study Right For You?

For our Season 9 opening episode, we're learning about agnostic treatments in cancer with Dr. Richard Schilsky of ASCO, who discusses the  TAPUR Study. You may wonder, what is TAPUR and how does it relate to agnostic treatments?  The pioneer behind the study, Dr. Schilsky, explains clinical trials for agnostic therapeutics, how you can join a TAPUR trial, and what to expect.

Read More
Tumor-Agnostic Therapies: Is This a Paradigm Shift in Cancer Care?
Diagnosis and Treatment, Clinical Research, Research, Novel Treatments, Medical Community Our MBClife Diagnosis and Treatment, Clinical Research, Research, Novel Treatments, Medical Community Our MBClife

Tumor-Agnostic Therapies: Is This a Paradigm Shift in Cancer Care?

Do tumor-agnostic therapies represent a radical shift in oncology? Join us on this 1st part of a 2-part series as Dr. Joshua Drago of MSKCC answers this question and points out the advantages as well as the treatment limitations of agnostic therapeutics.

Read More
Dr. Stephanie Graff: Understanding Progression
Essential Knowledge, Medical Community, Challenges and Barriers, MBC Imaging and Profiling, Difficult to Treat, Novel Treatments, Obstacles to Better Outcomes, Diagnosis and Treatment, Entities of Cancer Our MBClife Essential Knowledge, Medical Community, Challenges and Barriers, MBC Imaging and Profiling, Difficult to Treat, Novel Treatments, Obstacles to Better Outcomes, Diagnosis and Treatment, Entities of Cancer Our MBClife

Dr. Stephanie Graff: Understanding Progression

What does it mean when our cancer shows progression? And how do we know when that happens? The Our MBC Life team gets the lowdown from Dr. Stephanie L. Graff.

Read More